Group 2 innate lymphoid cells (ILC2) are known to contribute to the pathology of allergic asthma but the molecular mechanism by which they are getting activated are not fully known. Here authors show that the mTORC1 pathway, partly via neuromedin U receptor 1 (NMUR1), plays a pivotal role in ILC2 cell activation, and that inhibition of this signalling alleviates allergic asthma in mice.
- Dongdi Wang
- Lin Hu
- Lei Shen
